Anne De Groot

CSO at EpiVax Therapeutics

About

Anne De Groot is the Chief Scientific Officer at EpiVax Therapeutics. Anne has been a Professor and Director of the Institute for Immunology and Informatics at the University of Rhode Island since September 2008. In January 2017, Anne began the process of spinning out a new Personalized Cancer Vaccine company, now headed by Gad Berdugo, CEO. This new company is in the Seed Stage of Investment. The company's technology is called Ancer. It is a fully integrated, end-to-end Personal Mutanome to Vaccine computational pipeline for cancer patients. Working with experts at their Alma Mater, Pritzker School of Medicine (Gary Steinberg) and with Tufts New England Medical Center experts Leni Ramos and Judy Lieberman, Anne is working in unison towards this noble objective: Every cancer patient deserves their own personalized cancer vaccine. Anne is thrilled to be participating in this new genome-to-vaccine program, using their extensively validated technology and novel insights into the nature of human immune response. Mike Princiotta is now the CSO.


Anne De Groot completed their undergraduate degree at Smith College in Biology and then attended The University of Chicago Pritzker School of Medicine to earn their M.D. Anne also attended the University of Chicago Laboratory Schools.


They work with Guilhem Richard - CTO, William Martin - Co-Founder, COO & CIO, and Gary Steinberg - Chief Medical Officer. Their manager is Nicole Ruggiero, CEO.

Links

Timeline

  • CSO

    Current role

  • Co-Founder, CEO & CSO

View in org chart

The Org
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.